MIMETAS
MIMETAS develops predictive Organ-on-a-Chip cell culture models for better, more reliable and tailored medicines. A significant gap exist between the predictive value of various in vitro and animal screening models and a patient. MIMETAS fills this gap with its OrganoPlates featuring organotypic screening models that have an improved predictability and can be screened at a high throughput.
MIMETAS
Industry:
3D Technology Biotechnology Health Care Information Technology
Founded:
2013-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.mimetas.com
Total Employee:
101+
Status:
Active
Contact:
(318) 588-8316
Email Addresses:
[email protected]
Total Funding:
32.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network JsDelivr Facebook Sharer Amazon Virginia Region Pardot LiveChat Lighttpd
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Mimetas
European Life Sciences Growth Fund
European Life Sciences Growth Fund investment in Series B - Mimetas
OostNL
OostNL investment in Series B - Mimetas
Cathay Venture
Cathay Venture investment in Series B - Mimetas
Korys
Korys investment in Series B - Mimetas
InnovationQuarter
InnovationQuarter investment in Series B - Mimetas
Aglaia BioMedical Ventures
Aglaia BioMedical Ventures investment in Series B - Mimetas
PMV
PMV investment in Series A - Mimetas
Zeeuws Investerings Fonds
Zeeuws Investerings Fonds investment in Series A - Mimetas
Official Site Inspections
http://www.mimetas.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.93 K
- Host name: fabro.ntrx.eu
- IP address: 217.72.203.142
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Mimetas" on Search Engine
MIMETAS - Wikipedia
Mimetas is a privately owned biotechnology company developing human organ-on-a-chip tissue models and products for drug development. The company also is involved in the testing of chemicals along with food and personalized medicine applications. The company is based in Oegstgeest and Enschede, The Netherlands, with subsidiairies in Gaithersburg (MD), United States, and Tokyo, Japan. Mimetas was founded in 2011 by Paul Vulto, Jos Joore, Bas Trietsch and Tho…See details»
MIMETAS | LinkedIn
MIMETAS | LinkedIn. Biotechnology Research. Human Tissue Models for Better Therapies. View all 109 employees. About us. We strive to contribute to groundbreaking therapies with our screenable,...See details»
Our Technology - MIMETAS
MIMETAS offers OrganoPlates and develops human tissue and disease models for tomorrow’s medicines, chemicals and food. Check the applications, products, or work …See details»
Services - MIMETAS
Expand your drug discovery capacity, shoulder to shoulder with our scientific team. Proprietary human disease biology in the OrganoPlate ® platform. Together we make …See details»
Trust Built on Excellence - mimetas.com
MIMETAS elected most innovative company of the Netherlands. MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules. MIMETAS participates in €325 …See details»
MIMETAS | LinkedIn
MIMETAS | LinkedIn. Biotechnology Research. Human Tissue Models for Better Therapies. View all 112 employees. About us. We strive to contribute to groundbreaking therapies …See details»
MIMETAS to Participate in Holomicrobiome Institute, Backed by …
Mar 15, 2024 MIMETAS to Participate in Holomicrobiome Institute, Backed by €200 Million from Dutch Cabinet. Amsterdam, March 15, 2024 – The government of the Netherlands …See details»
MIMETAS elected most innovative company of the Netherlands
The winner of the prestigious Dutch Innovation Prize 2022 is the result of a nomination by an expert jury and the public vote. As the 2022 award winner, MIMETAS succeeds …See details»
OrganoPlate® Graft - MIMETAS
OrganoPlate ® Graft is developed for grafting tissues to a vascular bed. Its open-top design makes it possible to receive target tissues for studying interaction with a vascular bed. It uniquely facilitates perfusion of the …See details»
MIMETAS Elected Most Innovative Company of the Netherlands
Nov 2, 2022 MIMETAS (Leiden, The Netherlands) is a global leader in human-relevant disease models for drug discovery and development. Based on its proprietary …See details»
Mimetas - Crunchbase Company Profile & Funding
About. MIMETAS develops organ-on-a-chip tissue- and disease models for better, more reliable, and tailored medicines. Leiden, Zuid-Holland, The Netherlands. 101-250. Grant. …See details»
MIMETAS' Recent Milestones in Advancing Drug Discovery …
The strategic moves by MIMETAS, including the partnership with Astellas Pharma and the launch of ASC-derived tubular organoids, highlight the increasing relevance of organ-on …See details»
MIMETAS | Leiden Bio Science Park
MIMETAS is a global leader in the fast-growing ‘organ-on-a-chip’-field. We aim to improve the medicine development process by utilizing better predictive cell culture models. Our …See details»
Products - MIMETAS
OrganoPlate ® is the solution for all in vitro tissue culture applications. It enables unique novel tissue cultures and applications. Discover the OrganoPlate ® family here. Use …See details»
Careers - MIMETAS
The partnership comprises utilizing MIMETAS’ comprehensive tumor models to support the next generation of immuno-oncological therapies. Nice to meet you Highly talented, …See details»
Mimetas - Contacts, Employees, Board Members, Advisors
Organization. Mimetas. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 9. Number of Board Member …See details»
Mimetas - Updates, News, Events, Signals & Triggers - Crunchbase
Jan 18, 2024 Mimetas is focused on advancing 3D cell culture technologies. Their research includes a method and apparatus for forming microfluidic gel structures that …See details»
Mimetas - Funding, Financials, Valuation & Investors - Crunchbase
Mimetas has raised a total of. $32.4M. in funding over 5 rounds. Their latest funding was raised on Jan 1, 2019 from a Grant round. Mimetas is funded by 8 investors. EASME - …See details»